2
Clinical Trials associated with Reassortant Rotavirus Vaccine, live, Oral, Trivalent (Vero Cell) (Lanzhou Institute of Biological Products) [Translation] Phase III clinical study of Ⅲ-valent rotavirus gene reassortant vaccine
主要目的 考核和评价Ⅲ价轮状病毒基因重配疫苗接种人体后对轮状病毒胃肠炎的预防效果和降低重症轮状病毒腹泻的效力。
次要目的
1.进一步考察疫苗接种后安全性。
2.进一步评价疫苗免疫原性。
3. 评价疫苗对各基因型轮状病毒的预防效果。
[Translation] Main purpose: To evaluate the preventive effect of rotavirus gastroenteritis and the effectiveness of reducing severe rotavirus diarrhea after vaccination with Ⅲ-valent rotavirus gene reassortment vaccine.
Secondary purpose:
1. To further investigate the safety of vaccination.
2. To further evaluate the immunogenicity of the vaccine.
3. To evaluate the preventive effect of the vaccine on various genotypes of rotavirus.
/ Unknown statusPhase 3IIT Phase Three Clinical Trials of Trivalent Rotavirus Genetic Reassortment Vaccine
Assessment and evaluation the rotavirus gastroenteritis prevention effect and severe rotavirus diarrhea reducing effectiveness of human body, which inoculate trivalent rotavirus genetic reassortment vaccine.
Start Date01 Aug 2012 |
Sponsor / Collaborator- |
100 Clinical Results associated with Reassortant Rotavirus Vaccine, live, Oral, Trivalent (Vero Cell) (Lanzhou Institute of Biological Products)
100 Translational Medicine associated with Reassortant Rotavirus Vaccine, live, Oral, Trivalent (Vero Cell) (Lanzhou Institute of Biological Products)
100 Patents (Medical) associated with Reassortant Rotavirus Vaccine, live, Oral, Trivalent (Vero Cell) (Lanzhou Institute of Biological Products)
100 Deals associated with Reassortant Rotavirus Vaccine, live, Oral, Trivalent (Vero Cell) (Lanzhou Institute of Biological Products)